Strides Pharma Science Limited has informed the Exchange about No Objection received from BSE Limited and NSE Limited for Reclassification of Shasun Enterprises LLP and Ambemata Securities from "Promoter Group" to "Public" category
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has received no-objection approvals from both BSE and NSE for reclassifying two entities — Shasun Enterprises LLP (formerly Devendra Estates LLP) and Ambemata Securities (Vimalkumar Srisrimal) — from the 'Promoter Group' category to the 'Public' category. The company had originally applied for this reclassification on May 26, 2025, under Regulation 31A of the SEBI Listing Regulations. Both stock exchanges granted their approval on July 10, 2025. This is a procedural clearance from the exchanges and paves the way for the formal reclassification.
This reclassification reduces the effective promoter group shareholding of Strides Pharma and shifts those shares into the public float, which could improve liquidity and align the shareholding structure with the entities' actual role. It is largely an administrative/structural change and is unlikely to have a significant direct impact on the stock price.